Theophylline (anhydrous) | 19211 | INJECTABLE;INJECTION | 4MG/ML

Theophylline anhydrous

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

70 API Suppliers, 35 USDMF, 8 CEP/COS, 6 JDMF, 1 EU WC, 2 KDMF, 8 NDC API, 26 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

FINISHED DOSAGE FORMULATIONS

270 FDF Dossiers, 183 FDA Orange Book, 29 Europe, 7 Canada, 4 Australia, 30 South Africa, 17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 160MG/100ML, INJECTABLE;INJECTION - 320MG/100ML, INJECTABLE;INJECTION - 40MG/100ML, INJECTABLE;INJECTION - 4MG/ML, SOLUTION, ELIXIR;ORAL - 80MG/15ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 3 SPI Pharma, 8 DKSH, 4 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 3 Kirsch Pharma, 1 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 15 BASF, 1 CD Formulation, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Finar, 10 Gangwal Chemicals, 4 Ideal Cures, 23 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 22 Roquette, 13 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders, 40 Coating Systems & Additives, 24 Direct Compression, 23 Thickeners and Stabilizers, 21 Granulation, 20 Solubilizers, 20 Parenteral, 19 Film Formers & Plasticizers, 18 Controlled & Modified Release, 17 Topical, 13 Lubricants & Glidants, 12 Taste Masking, 12 Co-Processed Excipients, 10 Emulsifying Agents, 8 Rheology Modifiers, 6 Chewable & Orodispersible Aids, 6 Disintegrants & Superdisintegrants, 6 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 16 News #PharmaBuzz

GLOBAL SALES INFORMATION

15 US Medicaid Prescriptions, 24 Regulatory FDF Prices

MARKET PLACE

22 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Exclusivities

1 US Exclusivities

REF. STANDARDS & IMPURITIES

1 EDQM, 5 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 19211 / DOSAGE - INJECTABLE;INJECTION - 4MG/ML

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
THEOPHYLLINE ANHYDROUS(UNII: 0I55128JYK) (THEOPHYLLINE ANHYDROUS - UNII:0I55128JYK)	THEOPHYLLINE ANHYDROUS	160mg in 100 \| 200mg in 100 \| 320mg in 100 \| 400mg in 100

Inactive Ingredients

Ingredient Name	Baxter Healthcare Corporation	Hospira, Inc.
DEXTROSE MONOHYDRATE(LX22YL083G)
WATER(059QF0KO0R)

Setid E18c0cee A592 4c78 E08e 9898b7d4bf12 Applno 19211 Form Injectable Injection Dosage 4mg Ml - Drug Product Composition: Theophylline (anhydrous)